Fanale, Michelle Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. [electronic resource] - British journal of haematology Jan 2014 - 258-65 p. digital Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't ISSN: 1365-2141 Standard No.: 10.1111/bjh.12630 doi Subjects--Topical Terms: AdultAgedAged, 80 and overAntibodies, Monoclonal, Humanized--pharmacologyAntineoplastic Agents--pharmacologyCD40 Antigens--antagonists & inhibitorsFemaleHodgkin Disease--drug therapyHumansLymphoma, Non-Hodgkin--drug therapyMaleMiddle AgedNeoplasm StagingTreatment OutcomeYoung Adult